+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Investcorp closes Rs 316 cr investment in NephroPlus

Nov 25, 2019, 13:41 IST
PTI
New Delhi, Nov 25 () Alternative asset manager Investcorp on Monday said it has closed Rs 316 crore investment in dialysis service provider NephroPlus.

The primary capital raised in this round will be utilised towards organic growth in India and taking the proven business model of NephroPlus to other markets, starting with South East Asia, Investcorp said in a statement.

Advertisement

"Earlier, investors in NephroPlus include Bessemer Venture Partners and IFC, who will continue to stay invested alongside Investcorp, with one of the earlier investors, SeaLink Capital, exiting," it added.

NephroPlus aims to build a regional network of dialysis centers spanning India and select countries in Asia and the Gulf Cooperation Council (GCC) region, the statement said.

"We look forward to supporting Vikram (NephroPlus Founder) to realize the full potential of the NephroPlus business model, both in India and abroad," Investcorp India, Co-Head of Private Equity Gaurav Sharma said.

Investcorp's investment in NephroPlus is in line with their strategy to tap into sustainable business models in the mass consumption driven Indian market, the statement said.

Advertisement

"My co-founder Kamal Shah and I are delighted to welcome Investcorp at this stage into NephroPlus. We selected them because of their strong global network in key markets where we intend to now focus, as well as their deep understanding and experience of investing in the healthcare space in India and across the globe in the US, Europe and Middle East," NephroPlus Founder and CEO Vikram Vuppala said. AKT AKT BAL BAL

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article